BioCanRx
Business Services · Canada · 11-50 Employees
View Company Info for Free
Overview
Headquarters
501 Smyth Rd, Ottawa, Ontario, K1H 8L6, ...Phone Number
(613) 739-6640Website
www.biocanrx.comRevenue
<$5 MillionIndustry
About BioCanRx
BioCanRx is dedicated to transforming cancer into curable diseases through innovative immune oncology research and the translation of technologies into clinical trials. The organization provides funding, expertise, training, and biomanufacturing facilities to researchers, playing a crucial role in the development and adoption of cancer immunotherapies. It also focuses on empowering the cancer community by enhancing accessibility and improving the patient experience. Additionally, BioCanRx supports the commercialization of homegrown innovations within Canada's healthcare system.Explore more
BioCanRx Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to BioCanRx
Compare insights from companies similar to BioCanRx, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
BioCanRx Tech Stack
A closer look at the technologies used by BioCanRx
See more technologies
Top Business Services Companies
Top companies in Australia by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding BioCanRx
Sign Up For FreeTo access detailed company insights
BioCanRx is dedicated to transforming cancer into curable diseases through innovative immune oncology research and the translation of technologies into clinical trials. The organization provides funding, expertise, training, and biomanufacturing facilities to researchers, playing a crucial role in the development and adoption of cancer immunotherap... Read More
